Aberrant activation of NF-κB is known to be associated with the progression of breast cancer [7], particularly the promotion of tumor cell invasion, migration, and metastasis through the upregulation of MMP-9 expression [8]. This evidence concerns the gene NFKB1 and breast cancer.